Cargando…

New Evidence for Homocysteine Lowering for Management of Treatment-Resistant Hypertension

Detalles Bibliográficos
Autores principales:	Elias, Merrill F, Brown, Craig J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976174/ https://www.ncbi.nlm.nih.gov/pubmed/34935029 http://dx.doi.org/10.1093/ajh/hpab194

Ejemplares similares

Medical foods for lowering homocysteine in hypertensive patients
por: Elias, Merrill F., et al.
Publicado: (2022)

Homocysteine Reduction for Stroke Prevention: Regarding the Recent AHA/ASA 2021 Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
por: Brown, Craig, et al.
Publicado: (2023)

Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels
por: Dierkes, Jutta, et al.
Publicado: (2007)

Homocysteine and masked hypertension
por: Joob, Beuy, et al.
Publicado: (2015)

Homocysteine and Thrombophilia in Pulmonary Hypertension
por: Spence, J. David
Publicado: (2022)

Dapagliflozin's effect on serum homocysteine in patients with hypertension complicated with insulin resistance
por: Yu, Xiaoqian, et al.
Publicado: (2023)

Intensive Blood Pressure Control Improves Cognitive Performance: Pushing the Envelope cum Judicia
por: Elias, Merrill F., et al.
Publicado: (2017)

Reply: Homocysteine and Thrombophilia in Pulmonary Hypertension
por: Lian, Tian-Yu, et al.
Publicado: (2022)

The Eye is the Window to the Kidney and Brain
por: Elias, Merrill F., et al.
Publicado: (2016)

Retinal Ganglion Cell Loss in Diabetes Associated with Elevated Homocysteine
por: Shindler, Kenneth S.
Publicado: (2009)

Homocysteine-Lowering Interventions in Chronic Kidney Disease
por: Badri, Shirinsadat, et al.
Publicado: (2021)

Homocysteine levels in normotensive children of hypertensive parents
por: Yıldırım, Ali, et al.
Publicado: (2016)

Beyond the evidence: treating pulmonary hypertension in the intensive care unit
por: Bauer, Seth R, et al.
Publicado: (2014)

Intracranial Venous Hypertension and Venous Sinus Stenting in the Modern Management of Idiopathic Intracranial Hypertension
por: Townsend, Robert K., et al.
Publicado: (2021)

Ultrasound renal denervation: the future of hypertension management?
por: Ali, Laiba, et al.
Publicado: (2023)

Commentary: “Lower is Better” — SPRINTing to STEPping up hypertension research? An historical perspective on hypertension trials
por: Yu, Yu-Ling, et al.
Publicado: (2021)

New insights into adipose tissue VEGF-A actions in the control of obesity and insulin resistance
por: Elias, Ivet, et al.
Publicado: (2013)

Fosfomycin for management of persistent female lower urinary tract infection
por: Joob, Beuy, et al.
Publicado: (2018)

Urinary Plasmin(ogen): New Predictor of Hypertension?
por: Kohan, Donald E.
Publicado: (2018)

Investigation of Homocysteine-Pathway-Related Variants in Essential Hypertension
por: Fowdar, Javed Y., et al.
Publicado: (2012)

Aspartame and cancer – new evidence for causation
por: Landrigan, Philip J., et al.
Publicado: (2021)

Pharmacy Management Methods in Canada, Including Lower-Cost Therapy for Heartburn
por: Jackson, Mark
Publicado: (2006)

Isothermic Dialysis-a New Panacea for Intradialytic Hypertension?
por: Ganguli, Anirban
Publicado: (2019)

Commentary: Managing treatment-resistant polypoidal choroidal vasculopathy – Evolving concepts
por: Agarwal, Divya, et al.
Publicado: (2022)

Beyond inpatient and outpatient care: alternative model for hypertension management
por: Ho, P Michael, et al.
Publicado: (2006)

Usefulness of Blood Pressure Measurement by Community Pharmacists in the Management of Hypertension
por: Sabater-Hernández, Daniel, et al.
Publicado: (2012)

Practical Implications of New Antibiotic Agents for the Treatment of Carbapenem-Resistant Enterobacteriaceae
por: Bradley, Nicole, et al.
Publicado: (2019)

Practical applicability of genetics for the prevention and treatment of hypertension
por: Silva, Alexandre Sérgio
Publicado: (2021)

Effect of renal denervation on long-term outcomes in patients with resistant hypertension
por: Liang, Bo, et al.
Publicado: (2021)

Commentary on the effects of gestational hypertension on new‐onset diabetes mellitus
por: Wang, Wen‐Chung, et al.
Publicado: (2013)

The new mechanism of cognitive decline induced by hypertension: High homocysteine-mediated aberrant DNA methylation
por: Wan, Chong, et al.
Publicado: (2022)

Evidence Regarding Pharmacogenetics in Pain Management and Cancer
por: Smith, D Max, et al.
Publicado: (2023)

A heuristic approach and heretic view on the technical issues and pitfalls in the management of penetrating abdominal injuries
por: Yilmaz, Tugba H, et al.
Publicado: (2010)

The differential diagnostic value of serum homocysteine for white coat hypertension
por: Guo, Shitian, et al.
Publicado: (2017)

The B-VITAGE trial: A randomized trial of homocysteine lowering treatment of depression in later life
por: Ford, Andrew H, et al.
Publicado: (2011)

The B-VITAGE trial: A randomized trial of homocysteine lowering treatment of depression in later life
por: Ford, Andrew H, et al.
Publicado: (2010)

The Usefulness of New-Generation Capsule Endoscopy in Patients with Portal Hypertensive Enteropathy
por: Nam, Seung-Joo, et al.
Publicado: (2018)

Treatment of atelectasis: where is the evidence?
por: Schindler, Margrid B
Publicado: (2005)

Best Practices for Managing Postpartum Hypertension
por: Kumar, Natasha Raj, et al.
Publicado: (2022)

Ethical issues in intervention studies on the prevention and management of diabetes and hypertension in sub-Saharan Africa
por: Shayo, Elizabeth, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cof0pi9ev6lkhff7hfr00odvju